SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000920465-20-000104
Filing Date
2020-06-22
Accepted
2020-06-22 17:17:46
Documents
7

Document Format Files

Seq Description Document Type Size
1 SC 13D a2020sc13d22june2020tetrap.htm SC 13D 61920
2 EXHIBIT 1 exhibitfy20tetraphase06may.htm EX-1 6749
3 EXHIBIT 2 ljpcttphmergeragreementcov.htm EX-2 14949
4 EXHIBIT 3 exhibitfy20tetraphase19jun.htm EX-3 10163
5 ljpc8kimages0001.jpg GRAPHIC 21134
6 ljpc8kimages0002.jpg GRAPHIC 6330
7 ljpclogo.jpg GRAPHIC 13518
  Complete submission text file 0000920465-20-000104.txt   152133
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filed by) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Subject) CIK: 0001373707 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87366 | Film No.: 20979604
SIC: 2834 Pharmaceutical Preparations